Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00062946 · ClinicalTrials.gov registry record · Phase 2
PET Imaging of Dopamine in Healthy Study Participants
A Phase 2 study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT00062946 is a Phase 2 study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 45 participants.
The verdict
NCT00062946, a Phase 2 study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to measure molecules on or in cells that interact with a chemical in the nervous system, called dopamine. Investigators will obtain two kinds of images of the brain-a position emission tomography (PET) scan and a magnetic resonance imaging (MRI) scan. Thirty-eight participants aged 18 to 45 will be enrolled in this study. They must have no history of medical or psychiatric illness, including substance abuse. Participants will have four appointments at NIH. On the first visit, they will undergo a physical exam, a medical history, and lab tests. The second and third visits will involve PET scans and the fourth visit will involve an MRI scan. Participants will be compensated up to $430 for their involvement in this study.
Interventions
- DRUG (18F)fallypride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2003-06-17 |
| Est. Completion | 2007-08-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00062946
The ClinicalTrials.gov registry entry for NCT00062946 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which (18F)fallypride is the first listed.
NCT00062946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00062946 about?
NCT00062946 is a clinical study titled "PET Imaging of Dopamine in Healthy Study Participants". The purpose of this study is to measure molecules on or in cells that interact with a chemical in the nervous system, called dopamine. Investigators will obtain two kinds of images of the brain-a position emission tomography (PET) scan and a magnetic resonance imaging (MRI) scan. Thirty-eight parti...
What is the current status of trial NCT00062946?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2003-06-17. Estimated completion is 2007-08-15.
What interventions are being tested in trial NCT00062946?
The interventions under investigation include: (18F)fallypride (DRUG).
Who is sponsoring clinical trial NCT00062946?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.